Eyenovia

Eyenovia is a clinical-stage ophthalmic biopharmaceutical company dedicated to transforming the treatment of prominent eye diseases such as glaucoma, dry eye disease, and allergic eye conditions. Eyenovia's breakthrough piezo dispersion and microdosing technologies enable a range of first-class, next-generation ocular microtreatments designed to reduce ocular and systemic toxicity while improving the risk-benefit profile of both new and existing therapies.